Page last updated: 2024-12-07

3,5-diiodothyronine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,5-diiodothyronine: RN given refers to parent cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID123675
CHEMBL ID150462
CHEBI ID89575
SCHEMBL ID428139
MeSH IDM0095518

Synonyms (45)

Synonym
diiodo-l-thyronine
nsc-90468
diiodothyronine
nsc90469
nsc-90469
3,5-diiodothyronine
l-3,5-diiodothyronine
nsc90468
LS-14379
3,5-t2
u1y9gn485m ,
tyrosine, o-(4-hydroxyphenyl)-3,5-diiodo-
unii-u1y9gn485m
alanine, (3,5-diiodo-4-(-p-hydroxyphenoxy)phenyl)-
SGCUT00132
534-51-0
3,5-diiodo-dl-thyronine
TO_000037
CHEMBL150462
chebi:89575 ,
2-amino-3-[4-(4-hydroxyphenoxy)-3,5-diiodophenyl]propanoic acid
STL257459
o-(4-hydroxyphenyl)-3,5-diiodotyrosine
FT-0632330
FT-0614628
3,5-diiodo-dl-thryronine
3,5-diiodothyronine [mi]
3,5-diiodothyronine, dl-
dl-3,5-diiodothyronine
alanine, 3-(4-(p-hydroxyphenoxy)-3,5-diiodophenyl)-
3,5-diiodothyronine dl-form [mi]
dl-diiodothyronine
AKOS022133456
SCHEMBL428139
ZHSOTLOTTDYIIK-UHFFFAOYSA-N
3,5-diiodi-l-thyronine
d-o-(4-hydroxyphenyl)-3,5-diiodo-tyrosine
o-(4-hydroxyphenyl)-3,5-diiodo-tyrosine
(3,5-diiodo-4-(-p-hydroxyphenoxy)phenyl)-alanine
l-o-(4-hydroxyphenyl)-3,5-diiodo-tyrosine
4-(4-hydroxyphenoxy)-3,5-diiodophenylalanine
9-phenanthrylmagnesiumbromide
Q20888848
DTXSID60862141
2-amino-3-(4-(4-hydroxyphenoxy)-3,5-diiodophenyl)propanoic acid

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" System A amino acid transport activation was linear to hormone concentration, whereas the Na/H exchanger gave a bell-shaped dose-response curve, with a maximum at the physiological hormone concentration of 1 nM."( Short-term effects of thyroid hormones and 3,5-diiodothyronine on membrane transport systems in chick embryo hepatocytes.
De Vito, P; Incerpi, S; Leoni, S; Luly, P; Spagnuolo, S, 2002
)
0.58
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
organooxygen compoundAn organochalcogen compound containing at least one carbon-oxygen bond.
organonitrogen compoundAny heteroorganic entity containing at least one carbon-nitrogen bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Thyroid hormones production and peripheral downstream signaling effects2216

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1145381Binding affinity to rat thyroid hormone receptor1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Quantitative structure-activity relationships. 1. The modified Free-Wilson approach.
AID1146021Displacement of radiolabelled L-T3 from thyroid hormone receptor in intact rat hepatic nuclei relative to T31977Journal of medicinal chemistry, Jul, Volume: 20, Issue:7
Thyroxine analogues. 23. Quantitative structure-activity correlation studies of in vivo and in vitro thyromimetic activities.
AID1146023Binding affinity to thyroxine binding globulin (unknown origin) relative to T41977Journal of medicinal chemistry, Jul, Volume: 20, Issue:7
Thyroxine analogues. 23. Quantitative structure-activity correlation studies of in vivo and in vitro thyromimetic activities.
AID1146020In vivo antigoiter activity in rat1977Journal of medicinal chemistry, Jul, Volume: 20, Issue:7
Thyroxine analogues. 23. Quantitative structure-activity correlation studies of in vivo and in vitro thyromimetic activities.
AID1146022Binding affinity to rat hepatic solubilized nuclear thyroid hormone receptor relative to L-T31977Journal of medicinal chemistry, Jul, Volume: 20, Issue:7
Thyroxine analogues. 23. Quantitative structure-activity correlation studies of in vivo and in vitro thyromimetic activities.
AID161433Ability to displace L-[125I]thyoxine from the high affinity prealbumin binding site was expressed as ratio of its apparent association constant to that of DL-thyroxine1982Journal of medicinal chemistry, Jul, Volume: 25, Issue:7
Computer graphics in drug design: molecular modeling of thyroid hormone-prealbumin interactions.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (121)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (18.18)18.7374
1990's19 (15.70)18.2507
2000's18 (14.88)29.6817
2010's53 (43.80)24.3611
2020's9 (7.44)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.13 (24.57)
Research Supply Index4.85 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index4.00 (0.95)

This Compound (18.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.79%)5.53%
Reviews19 (15.08%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (0.79%)0.25%
Other105 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]